A
Alfredo Alberti
Researcher at University of Padua
Publications - 344
Citations - 13216
Alfredo Alberti is an academic researcher from University of Padua. The author has contributed to research in topics: Hepatitis B virus & Hepatitis C virus. The author has an hindex of 62, co-authored 342 publications receiving 12875 citations. Previous affiliations of Alfredo Alberti include University of Milan.
Papers
More filters
Journal ArticleDOI
Management of hepatitis C.
Alfredo Alberti,Luisa Benvegnù +1 more
TL;DR: This review addresses the main recent developments in the field of basic and clinical research on HCV, with particular reference to the clinical management of acute and chronic hepatitis C.
Journal ArticleDOI
Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C
Giada Sebastiani,A Vario,Maria Guido,Franco Noventa,Mario Plebani,R. Pistis,A. Ferrari,Alfredo Alberti +7 more
TL;DR: Stepwise combination of non-invasive markers of liver fibrosis improves the diagnostic performance in chronic hepatitis C and need for liver biopsy is reduced by 50-70% but cannot be completely avoided.
Journal ArticleDOI
Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy
Giada Sebastiani,Alfredo Alberti +1 more
TL;DR: In this paper, a set of algorithms that combine sequentially indirect non-invasive markers of liver fibrosis, reaching 90%-95% diagnostic accuracy with significant reduction in the need for liver biopsy, was proposed.
Journal ArticleDOI
Clinical and virological profiles in patients with multiple hepatitis virus infections.
P Pontisso,Maria Grazia Ruvoletto,Giovanna Fattovich,Liliana Chemello,Alberto Gallorini,Arturo Ruol,Alfredo Alberti +6 more
TL;DR: A reciprocal inverse relation between HBV and HCV replication is indicated and the biochemical activity and the histological severity of liver disease were lower in HCV RNA-positive/HBV DNA-negative patients, compared with HCVRNA (serum)-negative/HBv DNA-positive cases.
Journal ArticleDOI
Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results.
Eugene R. Schiff,Cjing Lung Lai,Stephanos J. Hadziyannis,Peter Nuehaus,Norah A. Terrault,Massimo Colombo,Hans L. Tillmann,Didler Samuel,Stefan Zuezem,Jean Pierre Villenueve,Sarah Arteburn,Katyna Borroto-Esoda,Carol L. Brosgart,Steven Chuck,Ahmad Obaid Shakil,Jhon Fung,Alfredo Alberti,Anna Lok,Antonio Picciotto,Francesco Torre,Caroline A. Riely,Christian Trepo,Thierry Bizollon,Danielle Bottaa-Fridlund,Rene Gerolami,David D. Douglas,Dinesh Ranjan,D Faust,Joerg Trojan,Edward Gane,Erica Villa,Modentina Boarino,Etienne Sokal,Peter Stärkel,Ferruccio Bonino,Brunetto Maurizio,Fred Gordon,Jo Anne Pratt,Frieder Berr,Ingolf Schiefke,Geoff McCaughan,Simone I. Strasser,Geoffrey Dusheiko,G.-P. Pageaux,Dominique Larrey,Giuseppe Pastore,Teresa Santantonio,Graeme J.M. Alexander,Tracy Woodall,Han Van Vlierberghe,Isabelle Colle,Hugh Harley,Jean Guggenheim,Aline Myx-Staccini,Jean Michel Metreau,Philippe Mavier,John M. Vierling,Tram Tran,Nigel Girgrah,Lisa M. Nyberg,Man-Fung Yuen,Mang Ma,Manuel Delgado Balnco,Manuela Merli,Paola Tanzilli,Mario Angelico,Daniele Di Paolo,Mario Rizzetto,Alfredo Marzano,Pietro Lampertico,Martín Prieto,Marina Berenguer,Martina Felder,Martina Sterneck,Marc Willems,Michael Charlton,Timothy J. Gunneson,Michael Ritter,Michael Voight,Judy Swift,Mitchell L. Shiffman,Nicholas Tassopoulos,Isidoros Klissas,Nikolai Naourmov,Patrick Chamouard,Patrick Marcellin,François Durand,Peter W Angus,Connelly Nathan,Pierluigi Toniutto,Elisabetta Fumo,Pietro Andreone,Carmela Cursaro,Rafael Bárcena,Fernando Garcia Hoz,Reinhard Zachoval,Maria Christina,Robert A. de Man,Herold J. Metselaar +98 more
TL;DR: Adefovir dipivoxil is effective and safe in wait‐listed or post–liver transplantation chronic hepatitis B patients with lamivudine‐resistant HBV and prevents graft reinfection with or without HBIg.